UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037856
Receipt number R000043164
Scientific Title Efficacy study of topical formulations (BH07, BH08)
Date of disclosure of the study information 2019/10/01
Last modified on 2020/11/11 09:36:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy study of topical formulations (BH07, BH08)

Acronym

Efficacy study of topical formulations (BH07, BH08)

Scientific Title

Efficacy study of topical formulations (BH07, BH08)

Scientific Title:Acronym

Efficacy study of topical formulations (BH07, BH08)

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confirm the efficacy of BH07 or BH08 on dry skin on the hands.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Transition of measured skin properties by instruments

Key secondary outcomes

Questionnaires for QOL


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Washout for 1week -> Applying test formulation (BH07) up to ten a day for 4 weeks -> Post-observation period for 1week

Interventions/Control_2

Washout for 1week -> Applying test formulation (BH08) up to ten a day for 4 weeks -> Post-observation period for 1week

Interventions/Control_3

Washout for 1week -> Applying control formulation up to ten a day for 4 weeks -> Post-observation period for 1week

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

69 years-old >=

Gender

Female

Key inclusion criteria

Subjects with dry skin on the hands

Key exclusion criteria

-Subjects with congenital skin diseases
-Ambulatory patient or subjects who are applying prescription drugs on the hands
-Subjects with any complications which affect the results of this study
-Subjects with menopausal trouble or on menopausal hormone therapy
-Pregnancies, lactations or subjects with suspicion of pregnancy.
-Subjects deemed inappropriate to participate in this study by person in charge of the examination

Target sample size

52


Research contact person

Name of lead principal investigator

1st name Azumi
Middle name
Last name Nagasawa

Organization

Kao Corporation

Division name

Personal Health Care Products Research

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

TEL

+81-285-68-9443

Email

nagasawa.azumi@kao.com


Public contact

Name of contact person

1st name Shotaro
Middle name
Last name Ito

Organization

Kao Corporation

Division name

Personal Health Care Products Research

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

TEL

+81-285-68-9443

Homepage URL


Email

itou.shoutarou@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-9861

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(東京都)


Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

48

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 30 Day

Date of IRB

2019 Year 09 Month 30 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2019 Year 12 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 11 Month 19 Day


Other

Other related information



Management information

Registered date

2019 Year 08 Month 30 Day

Last modified on

2020 Year 11 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043164


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name